DoxorubicinAntibiotics, AntineoplasticDrug Delivery SystemsDelivery, ObstetricDrug CarriersVincristineAntineoplastic Combined Chemotherapy ProtocolsRazoxaneCyclophosphamideLiposomesAntineoplastic AgentsDrug Resistance, NeoplasmPolyethylene GlycolsCell Line, TumorP-GlycoproteinNanoparticlesBreast NeoplasmsDrug Resistance, MultiplePrednisonePaclitaxelPregnancyEtoposideDose-Response Relationship, DrugVinblastineCesarean SectionDelivery of Health CareCisplatinDrug Administration ScheduleTreatment OutcomeNanocapsulesGene Transfer TechniquesDaunorubicinCell SurvivalTumor Cells, CulturedApoptosisDrug SynergismLeukemia P388CardiotoxinsHydroxyethylrutosideCombined Modality TherapyIfosfamideSarcomaParticle SizeTime FactorsGenetic TherapyBleomycinDrug ResistanceDrug Screening Assays, AntitumorAnthracyclinesGenetic VectorsPolymersChemistry, PharmaceuticalMice, NudeInfusions, IntravenousMethotrexateMitoxantroneProdrugsDrug CompoundingSurvival AnalysisNanomedicineDisease-Free SurvivalDelayed-Action PreparationsAntineoplastic Agents, PhytogenicHeartCardiomyopathiesHeart DiseasesNeoplasmsTissue DistributionXenograft Model Antitumor AssaysVerapamilPharmaceutical VehiclesOsteosarcomaFluorouracilPolyethyleneimineTaxoidsNeoplasm TransplantationInfant, NewbornDNA Topoisomerases, Type IIPregnancy OutcomeMicellesPolyglycolic AcidChemotherapy, AdjuvantOvarian NeoplasmsSurvival RateLung NeoplasmsNaphthacenesProcarbazineChitosanObstetric Labor ComplicationsRNA, Small InterferingAclarubicinEpirubicinObstetric Labor, PrematureInjections, IntravenousBone NeoplasmsMyocardiumSoft Tissue NeoplasmsTransfectionInhibitory Concentration 50Leukopenia